Alpha Cepheus LLC v. Chu

CourtDistrict Court, D. New Jersey
DecidedDecember 20, 2019
Docket2:18-cv-14322
StatusUnknown

This text of Alpha Cepheus LLC v. Chu (Alpha Cepheus LLC v. Chu) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Alpha Cepheus LLC v. Chu, (D.N.J. 2019).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

ALPHA CEPHEUS, LLC, et al.,

Plaintiffs, Civil Action No. 18-14322 v.

OPINION CHINH CHU, et al.,

Defendants.

ARLEO, UNITED STATES DISTRICT JUDGE: THIS MATTER comes before the Court on Defendants Chinh Chu’s (“Chu”), Douglas Newton’s (“Newton”) and Truc To’s (“To”) (collectively “Defendants”) Motions to Dismiss, ECF Nos. 70 & 71, Plaintiffs Paul Parmar (“Parmar”) and Alpha Cepheus, LLC’s, First United Health, LLC’s, Constellation Health, LLC’s, Naya Constellation Health, LLC’s, Constellation Health Investment, LLC’s (“CHI,” and together with Alpha Cepheus, LLC, First United Health, LLC, Constellation Health, LLC, Naya Constellation Health, LLC, the “LLC Plaintiffs”)1 Amended Complaint, ECF No. 65. For the reasons stated herein, the motions are granted. I. BACKGROUND A. Factual Background This action arises from a transaction to take a medical billing company private, uncovering an alleged fraud by its the senior officers and shareholders.

1 Alpha Cepheus, LLC is a Delaware limited liability, and a 49.6% shareholder in Constellation Health Technologies, Inc. Am. Compl. ¶ 31. The remaining LLC Plaintiffs owned shares in Constellation Health Technologies, Inc., before the “go private” transaction that is the subject of this litigation, and are currently shareholders of Alpha Cepheus, LLC. Id. ¶¶ 32-35. Parmar is the manager of the LLC Plaintiffs. Id. ¶ 36. 1. Parmar, CHT and the “Empty Shell” LLCs In 2012, Parmar and others acquired Orion Healthcorp, Inc., a medical billing, collections and physician practice management company. Am. Compl. ¶ 57. They merged the company into Constellation Healthcare Technologies, Inc. (“CHT”), which they later took public, listing CHT’s shares on the London Stock Exchange’s Alternative Investment Market (“AIM”). Id. ¶ 60. CHT

grew its business by acquiring existing medical billing and practice management companies, to use their existing customer lists and relationships. Id. ¶ 59. CHT followed a “common pattern” for its acquisitions, first forming a “shell” subsidiary limited liability company (“LLC”), with the intention of merging the proposed target into the shell. Id. ¶ 61. “[E]very acquisition of CHT” followed this pattern, and “the majority of these shell [LLCs] were filled, but two remained unfilled: Phoenix Health LLC (‘Phoenix’) and MDRX Medical Billing, LLC (‘MDRX’).” Id. ¶¶ 61-62. A third shell LLC, Northstar First Health, LLC (“Northstar”) “was filled, but with a smaller subsidiary than expected.” Id. ¶ 62. While CHT was a public company, it regularly sought financing in the form of secondary share offerings and announced its activities via press releases. Id. ¶¶ 63-64. CHT issued press

releases concerning Phoenix, MDRX, and Northstar, which they concede were inaccurate. Id. These included: (1) an announcement that CHT acquired Northstar on September 16, 2015, when Northstar was actually a shell LLC filled by Vachette Business Services, LLC; (2) an announcement that CHT acquired Phoenix on September 18, 2015, when Phoenix was a shell LLC created by CHT; and (3) an announcement on February 10, 2016 that CHT acquired MDRX, when MDRX was also a shell LLC created by CHT. Id. ¶¶ 65-66, 68. 2. CC Capital’s Interest in CHT In September 2015, Parmar met Chu. Am. Compl. ¶ 70. Chu is the Senior Managing Director and Founder of nonparty CC Capital, LLC (“CC Capital”), a private equity firm. Id. ¶ 37. Defendant Newton is a CC Capital Senior Managing Director. Id. ¶ 39. In January 2016, Chu began to show interest in acquiring CHT, de-listing its stock and taking it private. Id. ¶¶ 70-71. CC Capital’s first set of bids were unsuccessful. After an initial disagreement, Parmar and Chu agreed that Parmar would hold a minority position after the deal “and give limited voting rights to CC Capital on the equity [he and the LLC Plaintiffs] continue to hold.” Id. ¶ 74. In order

to raise the price offered for CHT, Parmar agreed to contribute $10 million to the purchase. Id. ¶ 77. As a result of his position as a buyer, CHT’s board required Parmar to recuse himself from bid evaluations and formed a special committee to evaluate the offer. Id. ¶¶ 77-78. Chu directed CC Capital to hire defendant To, then a KPMG partner, to conduct due diligence. Id. ¶ 80. After receiving a fairness opinion from Duff & Phelps, CHT’s special committee rejected Chu and Parmar’s bid on August 23, 2016. Id. ¶ 86. At this time, Parmar did not want to proceed with the transaction, and told Chu and Newton as much. ¶¶ 87-88, 90. Parmar “was honest with Newton,” telling him that he wanted “more time to resolve the CHT issues,” while Newton responded that “Chu did not want to drop the deal and

that they would be happy to work out any of CHT’s issues with Parmar once they became partners.” Id. ¶ 92. Despite wanting to proceed with the transaction, on September 12, 2016 CC Capital withdrew its offer, allegedly in order to have Chu select advisors for a new CHT special committee. Id. ¶ 99. Chu then had his associates introduce Parmar to SunTrust Robinson Humphrey (“SunTrust”) and McGuireWoods LLP as potential financial and legal advisors for CHT. Id. ¶¶ 102-03. Before CC Capital withdrew its first bid, To and KPMG began performing due diligence. Id. ¶ 108. CC Capital had access to CHT’s proprietary internal database that accurately represented all “data, collections and fees” concerning CHT, and thus Plaintiffs allege that Chu and To “had actual knowledge” that MDRX, Northstar and Phoenix were not as represented by CHT, and that “the empty shells had no assets, revenue or employees,” Id. ¶¶108-09. Plaintiffs also claim that other audit data provided to To and Chu indicate that they “knew that the empty shells were indeed empty.” Id. ¶¶ 109-13.2

3. The Deal Closes CC Capital submitted another bid for CHT on September 14, 2016. Id. ¶ 119. CHT formed a new independent committee and rejected the offer, without the benefit of a new fairness opinion.3 Id. ¶¶ 124, 129. CC Capital then raised its bid again, which the committee again rejected, after which all board members offered to resign. Id. ¶ 131. CC Capital then increased its bid “by 2 cents/share,” and at the request of the special committee’s legal counsel, included an offer of indemnity for the committee’s counsel and all board members, along with increased compensation for board members. Id. ¶ 133. The board approved this offer on November 29, 2016, with

defendant CHT Holdco LLC, an entity part owned by CC Capital and Plaintiffs, to purchase CHT. Id. ¶¶ 133-34. At the CHT board’s request, Chu agreed to add a 30-day “go shop” period, during which CHT could solicit competing bids. Id. ¶¶ 134-42. Plaintiffs allege that Chu set up this go shop period “to ensure that no other buyer could outbid him” and that he “improperly and corruptly influenc[ed] the bidding process” to ensure that his bid was successful. Id. ¶ 141, 145. Despite receiving at least one other bid, CHT accepted CC Capital’s offer. Id. ¶ 145.

2 As further support for their contention that Chu and Newton knew that the shell LLCs were empty, Plaintiffs allege that in August 2016, a reporter from the Financial Times newspaper “began asking about the legitimacy of the acquisitions of Phoenix, Northstar and MDRX.” Id. ¶ 116. However, “Chu directed his public relations firm to try to kill the Financial Times story” and “let the deal proceed to closing.” Id. ¶ 117. 3 Plaintiffs allege that although Chu arranged to have Parmar and the CHT board hire SunTrust to be the board’s second financial advisor, SunTrust resigned after it was unable to provide a fairness opinion with a price in the range Chu wanted. Am. Compl. ¶¶ 102-03, 124-29.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

H. J. Inc. v. Northwestern Bell Telephone Co.
492 U.S. 229 (Supreme Court, 1989)
Dura Pharmaceuticals, Inc. v. Broudo
544 U.S. 336 (Supreme Court, 2005)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
In Re Aetna, Inc. Securities Litigation
617 F.3d 272 (Third Circuit, 2010)
In Re Insurance Brokerage Antitrust Litigation
618 F.3d 300 (Third Circuit, 2010)
United States v. Paul Bergrin
650 F.3d 257 (Third Circuit, 2011)
United States v. Leonard A. Pelullo
964 F.2d 193 (Third Circuit, 1992)
EP MedSystems, Inc. v. EchoCath, Inc.
235 F.3d 865 (Third Circuit, 2000)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
E.I. duPont De Nemours & Co. v. Florida Evergreen Foliage
744 A.2d 457 (Supreme Court of Delaware, 1999)
Deuley v. DynCorp International, Inc.
8 A.3d 1156 (Supreme Court of Delaware, 2010)
Fraser v. Nationwide Mutual Insurance
352 F.3d 107 (Third Circuit, 2003)
In Re Nickelodeon Consumer Privacy Litigation
827 F.3d 262 (Third Circuit, 2016)
Austin Williams v. Globus Medical Inc
869 F.3d 235 (Third Circuit, 2017)
Seven Investments, LLC v. AD Capital, LLC
32 A.3d 391 (Court of Chancery of Delaware, 2011)
Kehr Packages, Inc. v. Fidelcor, Inc.
926 F.2d 1406 (Third Circuit, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
Alpha Cepheus LLC v. Chu, Counsel Stack Legal Research, https://law.counselstack.com/opinion/alpha-cepheus-llc-v-chu-njd-2019.